Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.

Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA.

Immunity. 2005 Feb;22(2):163-73.

2.

Progress towards the development of a HIV-1 gp41-directed vaccine.

McGaughey GB, Barbato G, Bianchi E, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller MD, Pessi A, Shiver JW, Bogusky MJ.

Curr HIV Res. 2004 Apr;2(2):193-204. Review.

PMID:
15078183
3.

Prospects of HIV Env modification as an approach to HIV vaccine design.

Hu SL, Stamatatos L.

Curr HIV Res. 2007 Nov;5(6):507-13. Review.

PMID:
18045108
4.

The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Montero M, van Houten NE, Wang X, Scott JK.

Microbiol Mol Biol Rev. 2008 Mar;72(1):54-84, table of contents. doi: 10.1128/MMBR.00020-07. Review.

5.

Rescue of a broader range of antibody specificities using an epitope-masking strategy.

Ditzel HJ.

Methods Mol Biol. 2002;178:179-86. Review. No abstract available.

PMID:
11968486

Supplemental Content

Support Center